Companies

Replimune

Mentioned in 1 analyzed podcast episode across 1 show

Mentioned On

Episode Mentions

Biotech Hangout

Biotech Hangout · May 8, 2026

Episode 182 - May 8, 2026

Oncolytic virus therapy for melanoma rejected twice by FDA despite community support; regulatory decision criticized

Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis